Ignasi J. M.
- Country
- Spain
- Department
- Ophthalmology
Research Overview
- Phase 2 Randomized Placebo-Controlled Study of Subcutaneous ADX-038 in Adults With Geographic Atrophy Secondary to Age-Related Macular Degeneration
- Evaluation of Efficacy and Safety of Intravitreal EYE103 Versus Ranibizumab in Diabetic Macular Edema: A Randomized, Double-Masked, Multi-Center Study
- Phase 2 Double-Masked Placebo-Controlled Dose-Finding Study of Danicopan in Geographic Atrophy Secondary to Age-Related Macular Degeneration
Data & Insights
Has run more than one trial at 129 of 221 partner sites.
Specializations
Ophthalmology and Retinal Diseases
This investigator specializes in treating age-related macular degeneration with particular emphasis on geographic atrophy, conducting innovative research into complement inhibition therapies.
- Geographic Atrophy Management
- Complement System Modulation
- Intravitreal Therapeutics
The investigator's work encompasses systemic and local treatment approaches for retinal conditions.
Visual Function and Assessment
Expertise in evaluating visual acuity outcomes and conducting comprehensive assessments using standardized methodologies such as ETDRS protocols.
- Best-Corrected Visual Acuity Measurement
- Visual Function Testing
- Long-term Vision Monitoring
Focus on quantitative assessment of vision improvement in retinal disorders.
Retinal Therapeutics
Active involvement in evaluating novel treatments for diabetic macular edema and comparing various therapeutic approaches including anti-VEGF treatments.
- Advanced Drug Delivery Systems
- Combination Therapy Approaches
- Novel Therapeutic Agents
Investigates both established and experimental treatments for retinal diseases.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.